Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5068-28-0

Post Buying Request

5068-28-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5068-28-0 Usage

Description

Boc-S-Benzyl-L-cysteine is a white micro-crystalline powder with unique chemical properties that make it a valuable compound in various applications, particularly in the field of peptide synthesis.

Uses

Used in Pharmaceutical Industry:
Boc-S-Benzyl-L-cysteine is used as a building block for the enzymatic synthesis of peptides, specifically in the creation of HIV1 protease inhibitors. Its incorporation into the synthesis process aids in the development of effective treatments against HIV1 by enhancing the activity and selectivity of the resulting peptides.
Used in Chemical Synthesis:
Boc-S-Benzyl-L-cysteine is also utilized as an intermediate in the synthesis of various organic compounds, taking advantage of its unique chemical properties to facilitate the formation of complex molecular structures.

Check Digit Verification of cas no

The CAS Registry Mumber 5068-28-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,6 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5068-28:
(6*5)+(5*0)+(4*6)+(3*8)+(2*2)+(1*8)=90
90 % 10 = 0
So 5068-28-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H21NO4S/c1-15(2,3)20-14(19)16-12(13(17)18)10-21-9-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,16,19)(H,17,18)/p-1/t12-/m0/s1

5068-28-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1666)  N-(tert-Butoxycarbonyl)-S-benzyl-L-cysteine  >98.0%(HPLC)(T)

  • 5068-28-0

  • 5g

  • 340.00CNY

  • Detail
  • Alfa Aesar

  • (H63736)  N-Boc-S-benzyl-L-cysteine, 98%   

  • 5068-28-0

  • 5g

  • 196.0CNY

  • Detail
  • Alfa Aesar

  • (H63736)  N-Boc-S-benzyl-L-cysteine, 98%   

  • 5068-28-0

  • 25g

  • 659.0CNY

  • Detail
  • Alfa Aesar

  • (H63736)  N-Boc-S-benzyl-L-cysteine, 98%   

  • 5068-28-0

  • 100g

  • 2636.0CNY

  • Detail
  • Aldrich

  • (15383)  Boc-Cys(Bzl)-OH  ≥99.0% (T)

  • 5068-28-0

  • 15383-5G

  • 478.53CNY

  • Detail

5068-28-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-S-Benzyl-L-cysteine

1.2 Other means of identification

Product number -
Other names S-benzyl N-Boc-cysteine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5068-28-0 SDS

5068-28-0Relevant articles and documents

Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and in Vivo Studies

Jung, Sascha,Fuchs, Natalie,Johe, Patrick,Wagner, Annika,Diehl, Erika,Yuliani, Tri,Zimmer, Collin,Barthels, Fabian,Zimmermann, Robert A.,Klein, Philipp,Waigel, Waldemar,Meyr, Jessica,Opatz, Till,Tenzer, Stefan,Distler, Ute,R?der, Hans-Joachim,Kersten, Christian,Engels, Bernd,Hellmich, Ute A.,Klein, Jochen,Schirmeister, Tanja

, p. 12322 - 12358 (2021/09/02)

Rhodesain is a major cysteine protease of Trypanosoma brucei rhodesiense, a pathogen causing Human African Trypanosomiasis, and a validated drug target. Recently, we reported the development of α-halovinylsulfones as a new class of covalent reversible cysteine protease inhibitors. Here, α-fluorovinylsulfones/-sulfonates were optimized for rhodesain based on molecular modeling approaches. 2d, the most potent and selective inhibitor in the series, shows a single-digit nanomolar affinity and high selectivity toward mammalian cathepsins B and L. Enzymatic dilution assays and MS experiments indicate that 2d is a slow-tight binder (Ki = 3 nM). Furthermore, the nonfluorinated 2d-(H) shows favorable metabolism and biodistribution by accumulation in mice brain tissue after intraperitoneal and oral administration. The highest antitrypanosomal activity was observed for inhibitors with an N-terminal 2,3-dihydrobenzo[b][1,4]dioxine group and a 4-Me-Phe residue in P2 (2e/4e) with nanomolar EC50 values (0.14/0.80 μM). The different mechanisms of reversible and irreversible inhibitors were explained using QM/MM calculations and MD simulations.

A comprehensive one-pot synthesis of protected cysteine and selenocysteine SPPS derivatives

Flemer, Stevenson

, p. 1257 - 1264 (2015/04/14)

A proof-of-principle methodology is presented in which all commercially-available cysteine (Cys) and selenocysteine (Sec) solid phase peptide synthesis (SPPS) derivatives are synthesized in high yield from easily prepared protected dichalcogenide precursors. A Zn-mediated biphasic reduction process applied to a series of four bis-Nα-protected dichalcogenide compounds allows facile conversion to their corresponding thiol and selenol intermediates followed by insitu S- or Se-alkylation with various electrophiles to directly access twenty one known Cys and Sec SPPS derivatives. Most of these derivatives were able to be precipitated in crude form out of petroleum ether in sufficient purity for direct use as peptide building blocks. Subsequent incorporation of these derivatives into peptide models nicely illustrates their viability and applicability toward SPPS.

Total synthesis and biological evaluation of (+)-kalkitoxin, a cytotoxic metabolite of the cyanobacterium Lyngbya majuscula

White, James D.,Xu, Qing,Lee, Chang-Sun,Valeriote, Frederick A.

, p. 2092 - 2102 (2007/10/03)

(+)-Kalkitoxin, a metabolite of the marine cyanobacterium Lyngbya majuscula, was synthesized from (R)-2-methylbutyric acid, (R)-cysteine, and (3S, 4S, 6S)-3,4,6-trimethyl-8-(methylamino)octanoic acid. A key step in the synthesis was installation of the anti,anti methyl stereotriad by means of a tandem asymmetric conjugate addition of an organocopper species to an α,β-unsaturated N-acyl oxazolidin-2-one followed in situ by α-methylation of the resultant enolate. The thiazoline portion of kalkitoxin was assembled by titanium tetrachloride catalyzed cyclization of a vinyl substituted amido thiol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5068-28-0